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Abstract  Arterial  spin  labeling  (ASL)  perfusion  is  a  MRI  technique  to  quantify  tissue  blood
ﬂow. ASL  is  a  non-invasive  technique  that  labels  the  protons  in  the  arterial  blood  by  radiofre-
quency pulses,  without  the  exogenous  injection  of  contrast  media.  This  article  has  three  goals:
1) present  the  principles  of  ASL  perfusion,  the  types  of  labeling  and  the  ways  to  obtain  theKidney mapping;  2)  specify  and  the  quality  criteria  for  the  mapping  obtained,  while  emphasizing  the
artifacts;  and  3)  describe  the  main  encephalic  and  renal  applications.
© 2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
The  study  of  tissue  perfusion  provides  functional  information  about  the  lesion  charac-
terization  and  the  prognosis  in  a  great  many  disorders.  Different  techniques  are  used  in
everyday  clinical  practice:  the  perfusion  CT-scan,  T2*-weighted  perfusion  MRI  (or  dynamic
susceptibility  contrast  MRI:  DSC-MRI)  and  the  techniques  of  nuclear  medicine,  in  particular
single-photon  emission  computed  tomography  (SPECT)  whose  clinical  use  is  much  easier
than  positron  emission  tomography  (PET).  However,  all  of  these  techniques  are  invasive
since  they  require  the  exogenous  injection  of  a  contrast  media  or  use  ionizing  radiation
(CT-scan  and  nuclear  medicine).  Since  the  early  1990’s,  a  quantitative  MRI  technique  has
been  developed  to  study  perfusion  without  contrast  media,  the  arterial  spin  labeling  (ASL)
perfusion  technique.  As  an  endogenous  tracer,  ASL  uses  arterial  water  protons  labeled
by  radiofrequency  pulses.  Many  technical  advances  (high  ﬁeld  MRI,  multichannel  coils,
parallel  imaging  in  particular)  have  contributed  to  the  development  of  this  technique
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France.
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y  limiting  the  main  disadvantage:  a  low  signal-to-noise
atio  (SNR).  Therefore,  ASL  reveals,  in  an  entirely  non-
nvasive  manner,  perfusion  anomalies  in  many  disorders,  in
articular  encephalic  diseases.  ASL  sequences  have  recently
ecome  available  in  clinical  MRI  scanners.  However,  their
se  in  everyday  clinical  practice  remains  conﬁdential.
This  article  aims  at  presenting  the  principles  of  ASL,  the
onditions  for  its  use  with  clinical  MRI  scanners  and  the  main
rtifacts  as  regards  clinical  use.  Although  ASL  has  been  suc-
essfully  used  to  study  renal  perfusion,  this  article  is  focused
n  the  study  of  cerebral  perfusion.
rinciple of arterial spin labeling perfusion
eneral principle of arterial spin labeling
t  consists  of  a  differential  technique  during  which  two
cquisitions  are  carried  out:  one  with  the  labeling  of  arte-
ial  protons  and  a  control  acquisition.  With  the  techniques
ost  often  used,  the  magnetic  labeling  of  arterial  protons
s  carried  out  upstream  from  the  volume  of  interest,  at  the
eck  vessels,  by  radiofrequency  pulses.  The  labeled  pro-
ons  then  migrate  via  the  arterial  vessels  towards  the  brain
issue  where  they  pass  from  the  capillary  compartment  to
he  extravascular  compartment.  At  time  TI  (inversion  time)
fter  the  pulsed  labeling,  corresponding  to  the  time  required
or  the  labeled  protons  to  perfuse  the  tissue,  the  images  are
cquired  with  a  rapid  imaging  technique  (Fig.  1).
The  control  acquisition  is  obtained  without  arterial  label-
ng.  The  arterial  protons  of  the  volume  of  interest  are  then  in
quilibrium  and  completely  relaxed.  The  subtraction  of  the
abeled  and  control  acquisitions  suppresses  the  signal  from
he  static  tissue  and  provides  a  perfusion-weighted  image
1].  The  difference  in  signal  is  only  several  percent.  Many
epetitions  of  labeled-controlled  paired  images  have  to  be
cquired,  and  averaged  to  ensure  an  adequate  SNR.
Under  several  conditions,  a  perfusion  quantiﬁcation
odel  may  be  used  to  obtain  the  quantitative  mapping
f  the  cerebral  blood  ﬂow  (CBF)  in  mL/100  g  tissue/min
Fig.  2).
igure 1. Principle for arterial spin labeling acquisition. Examples of a
2TIPS or STAR.
P
P
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ain methods for data acquisition
he  acquisition  of  data  involves  two  basic  steps:  the  label-
ng  of  the  circulating  blood  protons  and  the  acquisition  of
mages.
roton  labeling  techniques
here  are  three  main  techniques  of  proton  labeling:
ontinuous  labeling  (CASL),  pulsed  labeling  (PASL),  and
seudo-continuous  labeling  (pCASL).
ontinuous  labeling
ASL  is  the  method  initially  proposed  by  Williams  et  al.
n  1992  [1,2].  The  labeling  is  continuous  through  a  thin
lice  at  the  neck  level.  The  inversion  of  the  magnetization
s  obtained  by  the  joint  application  of  continuous  pulsed
adiofrequency  for  2 to  4  seconds  and  a  magnetic  ﬁeld  gra-
ient  in  the  direction  of  the  ﬂow.  Although  CASL  provides
igher  perfusion  contrast  than  other  types  of  labeling  [3],
t  has  two  major  disadvantages:  the  considerable  magne-
ization  transfer  (MT)  effects  and  the  high  level  of  the
nergy  deposited  in  the  tissue  (SAR).  The  MT  effects  cor-
espond  to  the  partial  saturation  of  macromolecules  and  a
eduction  in  the  signal  from  the  free-water  in  the  studied
olume.  Several  methods  have  been  developed  to  reduced
hese  MT  effects;  ﬁrst  for  single  slice  acquisitions  and  sec-
nd  for  multi-slice  acquisitions.  Their  principle  is  based  on
he  application  of  additional  pulsed  radiofrequencies  dur-
ng  the  control  acquisition,  although  at  the  price  of  a  high
AR  [4]. This  effect  can  be  avoided  by  using  labeling-speciﬁc
oils  differing  from  the  image  acquisition  coil  [5,6].
seudo-continuous  labeling
o  limit  the  duration  of  the  application  of  the  radiofrequency
ulse,  the  CASL  may  be  approached  by  the  use  of  several  RF
ulses,  using  the  body  coil.  This  method  called  ‘‘pseudo-
ontinuous  ASL’’  has  the  combined  advantages  of  CASL  and
ASL  [7].symmetrical pulsed arterial spin labeling sequences such as PICORE
ulsed  labeling
ASL  techniques  use  very  short  radiofrequency  pulses  over
arge  labeling  zones.  There  are  two  groups  of  PASL  sequences
Arterial  spin  labeling  (ASL)  perfusion:  Techniques  and  clinical  use  1213
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DFigure 2. General principle of arterial spin labeling.
that  differ  according  to  the  zone  of  labeling  with  respect  to
the  slices:  symmetrical  methods  and  asymmetrical  methods
[8].  The  basic  symmetrical  method,  ﬂow  alternating  inver-
sion  recovery  (FAIR),  uses  a  non-selective  inversion  pulse
during  the  control,  that  becomes  selective  with  the  addi-
tion  of  a  slice  selection  gradient  for  the  labeling  [9].  The
asymmetrical  methods,  for  which  the  ﬁrst  version,  echo-
planar  MR  imaging  and  signal  targeting  with  alternative  radio
frequency  (EPISTAR)  was  described  in  1994,  have  a  labeling
zone  with  a  thickness  of  10—15  mm,  located  upstream  from
the  volume  of  interest  [10].  With  the  EPISTAR  sequence,  an
inversion  pulse  provides  the  labeling  after  saturation  of  the
magnetization.  During  the  control  acquisition,  the  labeling
volume  is  located  downstream  from  the  volume  of  inter-
est  in  order  to  control  the  MT  effects.  Several  modiﬁcations
were  then  made  in  this  sequence  for  the  multi-slice  study
[11],  while  limiting  the  MT  effects  (TILT  sequence)  [12], to
improve  the  proﬁle  of  the  labeling  slice  (PICORE  sequence)
[13]  and  to  reduce  the  sensitivity  of  the  arterial  transit  time
(QUIPPS,  QUIPPS  II,  Q2TIPS  sequences)  [14,15].
Other  methods
Several  approaches  have  also  been  developed  to  obtain  the
selective  labeling  of  an  artery  to  study  its  downstream  terri-
tory  [16—18],  or  to  selectively  label  some  arterial  velocities
[19].
Image  acquisition
The  labeling  effect  of  ASL  is  weak.  Many  repetitions  of
labeled-controlled  paired  images  have  to  be  acquired,  and
averaged  to  ensure  adequate  SNR.  Due  to  its  satisfying  SNR
and  the  rapid  acquisition  limiting  the  movement  artifacts,
‘‘echo-planar  imaging’’  (EPI)  is  the  technique  mainly  used.
The  main  disadvantage  is  the  presence  of  distortions  in  the
regions  with  a  high  magnetic  susceptibility.
3D  sequences  have  been  developed  to  improve  the
quality  of  the  images.  It  is  possible  to  use  ultra-fast,  single-
shot  3D  sequences  combining  gradient  echo  and  spin-echo
acquisition  (GRASE)  [20].  Its  use  thereby  facilitates  the
elimination  of  the  signal  from  static  tissue  [21].  This  type
of  sequence  theoretically  provides  a  better  SNR,  a  better
A
t
fover  and  fewer  magnetic  susceptibility  artifacts  than  2D
PI  sequences.
ptimization with the clinical MRI scanner
nﬂuence of the MRI hardware
igh  magnetic  ﬁeld
he  use  of  high  magnetic  ﬁeld  MRI  signiﬁcantly  improves  the
uality  of  ASL  images  [22].  In  fact,  with  high  magnetic  ﬁeld,
here  is  a  higher  increase  in  signal  than  in  noise  and  there-
ore  an  increase  in  the  SNR.  In  addition,  the  lengthening  of
he  T1  of  tissue  and  therefore  the  proton  labeling  time  in
SL  helps  increase  the  perfusion  signal.  The  doubling  of  the
ignal  in  CASL  and  PASL  acquisitions  was  thereby  obtained  at
 and  4  T  when  compared  with  acquisitions  at  1.5  T  [3,23].
hased  array  coil
nother  approach  to  improve  the  SNR  of  ASL  is  the  use  of
hased  array  coils.  Due  to  the  sensitivity  of  the  elements
t  the  surface  of  the  coil,  the  SNR  is  increased  not  only  in
he  regions  close  to  the  coil,  such  as  the  cortex,  but  also
n  the  entire  image  [24].  The  absolute  quantiﬁcation  of  the
BF  is  not  affected  by  the  effects  of  the  sensitivity  pro-
le  of  the  coil  [25].  Thereby,  the  SNR  increases  with  the
umber  of  coil  elements  [26,27]. In  addition,  this  type  of
oil  enables  the  use  of  parallel  imaging  (PI).  PI  techniques
uch  as  sensitivity  encoding  (SENSE)  or  generalized  autocal-
brating  partially  parallel  acquisitions  (GRAPPA)  have  shown
o  improve  the  quality  of  images  [27]. This  improvement
s  especially  distinct  in  long  echo  train  sequences  such  as
PI.  The  possible  reduction  of  the  TE  mainly  reduces  the
agnetic  susceptibility  artifacts  [28].
ata processing and quantiﬁcationpplication  of  a  model  that  takes  into  account  the  labeling
ype  and  parameters  is  necessary  to  quantify  tissue  per-
usion  from  the  perfusion-weighted  image.
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signals  located  in  the  vascular,  arterial  or  venous,  deep
or  juxtacortical  structures.  The  linear  arterial  juxtacortical
hypersignals  should  be  differentiated  from  cortical  perfusion
(Fig.  3).  These  artifacts  are  related  to  the  presence  of
Table  1  How  to  optimize  the  quality  of  ASL  mapping?
Magnetic  ﬁeld 3  T  >  1.5  T
Reception  coil  Multi-element  coil  superior  to  the  bird
cage  coil
Type  of
labeling
According  to  indication  and  magnetic
ﬁeld:  PCASL  >  PASL  > CASLa
With  crushersb
Acquisition  of
images
3D  superior  to  2D
With  elimination  of  the  signal  from
static  tissue,  parallel  imaging
TE  As  short  as  possible
TR  Sufﬁciently  long  for  sufﬁcient
relaxation  of  the  labeled  protons
between  the  acquisitions
(TR  >  3000  ms)
TI  Sufﬁciently  long  to  give  enough  time
for  the  labeled  protons  to  reach  the
capillaries  but  sufﬁciently  short  to
avoid  excess  relaxation  of  the  labeled
protons
A  great  many  factors  intervene
(magnetic  ﬁeld,  type  of  labeling,
location  of  the  labeling  box,
saturation. .  .)
ASL: arterial spin labeling; PCASL: pseudo-continuous labeling;
PASL: pulsed labeling; CASL: continuous labeling.
a Multi TI is currently not available on clinical machines.214  
ata  pre-processing
efore  quantiﬁcation,  the  data  should  be  pre-processed  to
mprove  the  quality  of  the  images.  The  ASL  image  series  have
o  be  adjusted  to  correct  the  subject’s  movements.  They
ay  also  be  ‘‘denoised’’  using  the  high-resolution  anatom-
cal  image  (3D  T1)  segmentation  [29].  The  pre-processing
ethods  used  are  mainly  generic  methods.  However,  the
rocessing  of  ASL  data  also  requires  speciﬁc  developments.
utomatic  analysis  was  proposed  to  study  muscle  perfusion
y  ASL  with  automatic  rejection  of  images  during  the  detec-
ion  of  considerable  movement  and  with  the  search  for
haracteristic  pixels  of  vessels  by  a  cluster  analysis  [30].
oreover,  automatic  detection  methods  for  brain  vessels,
sing  explicit  models,  have  been  developed  to  facilitate
heir  elimination  during  multi-TI  acquisitions  [31].  Asllani
t  al.  have  also  proposed,  for  the  correction  of  partial  vol-
me  effects  in  the  quantiﬁcation  of  the  CBF,  an  algorithm
hat  regulates  the  quantiﬁcation  according  to  the  white  mat-
er  —  grey  matter  distribution  in  the  voxel  [32]. Moreover,
ells  et  al.  have  used  several  ASL  de-noising  methods.  They
emonstrated  that  different  methods,  in  particular  analysis
y  independent  components,  may  reduce  errors  in  the  esti-
ate  of  the  CBF  and  the  arterial  transit  time  (ATT)  without
 modiﬁcation  in  image  contrast  [33].
uantiﬁcation
he  subtraction  between  labeled  images  and  control  images
rovides  a  perfusion-weighted  image  (M).  The  relationship
etween  M  and  the  CBF  depends  on  the  proton  density  of
he  tissue,  the  relaxation  time  T1  of  the  labeled  tissue  and
lood,  as  well  as  their  difference.  It  also  depends  on  the
ransit  time  between  the  labeling  area  and  the  volume  of
nterest.
The  ﬁrst  model  proposed  to  quantify  the  CBF  was  based
n  several  hypotheses:  the  blood  is  considered  to  arrive  at
 constant  speed  and  the  labeled  protons  are  considered  to
e  a  diffusible  tracer  that  passes  into  the  tissue  as  soon  as
hey  arrive  [1,2].  Therefore,  it  was  possible  to  use  a  sin-
le  compartment  model  in  which  the  relaxation  time  of  the
abeled  protons  is  no  longer  that  of  the  labeled  blood  but
hat  of  the  labeled  tissue.  Several  improvements  were  then
uccessively  proposed  to  reach  the  general  kinetics  model
roposed  by  Buxton  et  al.  [34].  In  this  model,  the  difference
n  magnetization  between  the  labeled  and  control  images  is
escribed  by  using  a  convolution:
M  =  2  ·  Ma,0 ·  CBF  ·
t∫
0
c () · r (t −  ) · m (t −  )d  (1)
here  M0,  is  the  magnetization  at  equilibrium  in  an  arterial
lood  voxel,  c(t)  the  fractionated  arterial  input  function,
(t-)  the  output  of  the  labeled  protons  from  the  voxel  and
(t-)  the  effects  of  longitudinal  relaxation.
This  model  is  applicable  with  CASL  and  PASL  provided
hat  the  parameters  are  adapted.  However,  there  are  many
ources  of  quantiﬁcation  error:  the  transit  time,  the  vascu-
ar  artifacts,  the  form  and  efﬁcacy  of  the  inversion  pulse,
he  effect  of  the  dispersion  of  the  bolus,  the  blood-tissue
istribution  coefﬁcient  of  the  labeled  protons  and  the  mag-
etization  of  the  blood  at  equilibrium  [35].J.-C.  Ferré  et  al.
In  addition  to  the  CBF,  other  perfusion  parameters  may
e  estimated  with  ASL,  provided  that  speciﬁc  methods  of
cquisition  or  different  quantiﬁcation  models  are  used.  It  is
herefore  possible  to  quantify  the  arterial  arrival  time  (AAT)
nd  the  volume  of  arterial  blood  with  a  multi-TI  sequence,
uch  as  the  quantitative  STAR  labeling  of  arterial  regions
QUASAR)  sequence  [36].
rterial spin labeling quality criteria
able  1  sums  up  the  recommended  conditions  of  acquisition
o  ensure  optimum  quality  of  the  mapping  obtained.  The
uality  of  the  mapping  obtained  in  ASL  may  be  altered  by
everal  types  of  artifacts,  whether  or  not  speciﬁc  to  the
echnique  or  patient-related.
rterial spin labeling-speciﬁc artifacts
ascular  artifacts
ascular  artifacts  are  mainly  visible  with  PASL,  although  they
ay  also  be  visible  with  CASL.  They  correspond  to  hyper-b Bipolar gradients applied during the acquisition to eliminate
the intravascular signal.
Arterial  spin  labeling  (ASL)  perfusion:  Techniques  and  clinical  use  1215
Figure 3. Arterial artifacts. a: the arterial artifacts are visible in
the form of hypersignals in the anterior interhemispheric and lateral
Figure 5. Effect of the application of crushers. a: vascular arti-
facts (arrows); b: there is a major reduction in these artifacts when
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psulcus (arrow) with a TI of 1200 ms; b: with a TI of 1700 ms, these
artifacts are reduced and the parenchymatous signal increases.
labeled  protons  in  the  vessels.  In  the  arteries,  their  presence
is  often  related  to  the  arterial  transit  time.  For  example,  if
the  TI  chosen  is  too  short,  of  if  the  arterial  transit  time  is
high,  as  in  severe  carotid  stenosis,  the  labeled  blood  will  not
have  the  time  to  reach  the  capillaries  and  will  thereby  be
detected  in  the  arteries  (Fig.  4).  This  artifact  may  be  of  clin-
ical  value  since,  for  example,  it  is  an  indicator  of  presence
and  intensity  of  the  collateral  arterial  network  in  moyamoya
disease  [37].
One  way  to  reduce  the  signal  from  the  vessels  in  a
homogenous  manner  is  to  add  crushers.  They  are  bipolar
gradients  applied  in  several  directions  during  the  acquisi-
tion,  just  before  the  acquisition  of  images,  to  eliminate  the
rapid  ﬂow  (over  several  cms/s)  (Fig.  5)  [38,39].
Venous  artifacts  are  visible  with  long  TI  or  with  certain
types  of  labeling  such  as  the  FAIR  technique  [40].
Signal  loss  in  the  upper  slices
The  overall  loss  of  signal  in  the  upper  slices  is  induced  by
the  relaxation  of  labeled  protons  over  time.  This  artifact  is
especially  visible  in  the  upper  slices  with  a  caudocranial  2D
acquisition.  It  is  above  all  visible  at  1.5  T,  since  the  label-
ing  duration  is  shorter  due  to  the  shorter  T1  of  the  blood
(Fig.  6).  3D  acquisition  reduces  this  artifact  as  does  the  use
of  parallel  imaging  that  may  reduce  the  time  of  acquisition
of  slices,  therefore  the  time  between  the  slices  [25].
a
t
m
Figure 4. Arterial artifacts, effect of the arterial transit time. a: pati
visible on the 3D TOF sequence; b—c: the increase in the time of circul
areas resulting in an increase in the mean transit time on the magnetic su
for the visualization of the arterial artifacts (arrows) and the reduction ipolar crusher gradients are applied.
hysiological  hyperperfusion/hypoperfusion
reas  of  hypoperfusion  and  hyperperfusion  are  sometimes
isible  in  the  normal  perfusion  mapping  and  are  related  to
hysiological  modiﬁcations  in  the  perfusion.
reas  of  hyperperfusion
isible  in  the  occipital  region,  according  to  certain  authors,
hey  are  due  to  an  activation  of  the  visual  areas  in  the  MRI
nvironment  [41].  The  hyperperfusion  visible  in  the  internal
rontal  region  has  already  been  described  with  other  per-
usion  techniques  [42].  This  may  also  involve  phenomena
elated  to  the  transit  time  and  residual  vascular  signal
Fig.  7).
This  aspect  is  considered  as  normal  in  the  young  and
iddle-aged  subject  and  decreases  with  age  and  the  factors
f  cardiovascular  risk  [41,42].
reas  of  hypoperfusion
hese  areas  extend  from  the  frontal  and  occipital  horns  to
he  frontal  and  parieto-occipital  cortex  [43].  They  globally
orrespond  to  the  arterial  border-zones  (Fig.  8).  This  hypo-
erfusion  is  bound  along  the  TTA  of  these  regions  [43].  This
spect  may  be  associated  with  the  difﬁculty,  in  some  situa-
ions,  of  obtaining  a  reliable  CBF  measurement  in  the  white
atter  [44].
ent presenting a vasospasm following a subarachnoid hemorrhage,
ation in the middle, posterior and right posterior junctional brain
sceptibility perfusion mapping; d—e: the same mechanism accounts
of the perfusion signal in pulsed labeling.
1216  J.-C.  Ferré  et  al.
Figure 6. Loss of signal from the upper slices. These arterial spin labeling mappings demonstrate the progressive reduction in signal on
the slices acquired later and later. This effect is less distinct at 3 T although still present, and improved with a 3D acquisition and when the
TE may be reduced by parallel imaging.
Figure 7. Zones of physiological hyperperfusion. These perfusion-weighted images, in three different subjects, show the internal bilateral
occipital and frontal physiological hyperperfusion (circles).
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aigure 8. Zones of physiological hypoperfusion. These perfusio
abeling, show the physiological hypoperfusion of the junctional ter
ost-gadolinium  arterial  spin  labeling
adolinium  contrast  media  signiﬁcantly  reduce  the  T1  of  the
lood.  This  shortening  is  such  that,  after  labeling  by  ASL,  it
s  not  possible  to  detect  the  minor  difference  between  the
abeled  and  control  images  (Fig.  9).Therefore,  it  is  not  possible  to  carry  out  an  ASL  sequence
mmediately  after  the  injection  of  gadolinium.  A  minimum
f  12  hours  seems  necessary  with  respect  to  the  half-life  of
adolinium  contrast  media.
M
M
a
sighted images, in three different subjects, obtained with pulsed
ies (arrows).
on-speciﬁc artifacts
 certain  number  of  artifacts  are  not  ASL  speciﬁc,  but  have
n  effect  on  the  quality  and  homogeneity  of  the  mapping.agnetic  susceptibility  artifacts
agnetic  susceptibility  artifacts  are  related  to  the  rapid
cquisition  of  images  and  are  particularly  visible  with  EPI
equences.  They  are  visible  as  a  focal  reduction  in  perfusion
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aFigure 9. Arterial spin labeling after the injection of gadoliniu
gadolinium are not analysable, as in this case of secondary left par
at  the  base  of  the  skull,  in  the  temporal  and  frontal  region
(Fig.  10).  They  are  also  present  in  hematomas,  calciﬁca-
tions,  metal  materials  or  in  contact  with  early  post-surgical
changes.
One  way  to  reduce  these  artifacts  is  to  use  less  sensitive
methods  of  image  acquisition  such  as  True-FISP  or  3D  GRASE
and/or  use  parallel  imaging  [20,25,27,45].
Movement  artifacts
The  multiple  repetitions  required  to  obtain  a  satisfactory
SNR  make  the  sequence  sensitive  to  movement  artifacts.
As  in  BOLD-fMRI,  these  artifacts  may  also  produce  strips  at
the  periphery  of  the  brain  (Fig.  11)  [41].  These  artifacts
may  be  the  source  of  focal  or  diffuse  areas  of  false  hypo  or
I
s
f
b
Figure 10. Artifacts of magnetic susceptibility. a: the artifacts of magn
b: on the cerebral blood ﬂow mapping, they are visible in the form of a 
the application of parallel imaging (GRAPPA with a factor 2), reveal a red
CBF mapping (d).
Figure 11. Movement artifacts. The concentric circular images in hypo
of movement artifacts.e arterial spin labeling mapping obtained after the injection of
localization.
yperperfusion  (Fig.  12).  The  methods  of  adjustment  are
f  limited  efﬁcacy  when  the  movements  are  sudden.  It  is
herefore  preferable  to  exclude  from  the  analysis  all  images
verly  subject  to  movement.
ensitivity  of  the  coil  elements
he  sensitivity  of  the  different  elements  in  a  phase  array
oil  differs  slightly.  If  an  element  is  defective  or  if  the  sensi-
ivity  differs  greatly  from  the  other  elements,  this  results  in
 peripheral  focal  area  where  the  perfusion  differs  (Fig.  13).
t  is  necessary  to  conﬁrm  this  artifact  by  obtaining  a second
equence  acquisition  by  positioning  the  patient’s  head  dif-
erently  in  the  coil.  A  post-treatment  correction  may  also
e  added  by  using  M0 mapping  [41].
etic susceptibility are clearly visible (circles) on the native images;
focal reduction in perfusion; c—d: the same images acquired after
uction in these artifacts on the native images (c) as well as on the
- and hypersignal around the brain (arrows) attest to the presence
1218  J.-C.  Ferré  et  al.
Figure 12. Movement artifacts. a—b: if the patient moves during the acquisition, the mapping appears more noised with a globally weaker
signal (a), when compared with the images acquired without movement (b).
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ASL  has  been  applied  in  most  of  the  neuroscience  ﬁelds,
on  healthy  subjects  and  patients,  thanks  to  its  non-invasive
F
t
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tigure 13. Sensitivity of a phase array coil element. These perfu
how that the signal appears greater in all subjects when near one 
arallel  imaging  artifacts
hese  non-speciﬁc  artifacts  are  less  distinct  on  perfusion
apping  than  on  the  native  imaging,  due  to  the  subtraction
25].  With  the  SENSE  and  mSENSE  techniques,  these  artifacts
ppear  as  aliasing  [46].  With  the  GRAPPA  technique,  these
rtifacts  produce  a  diffuse  or  even  grainy  image  with  high
cceleration  factors  (Fig.  14)  [27].
n
t
igure 14. Parallel imaging artifacts. Parallel imaging artifacts are abo
he parallel imaging factor (here factor 2 and 4). With the generalized 
hey are the cause of a grainy appearance of the image, while with the
he cerebral blood ﬂow mapping (lower line), they are less clearly visibl-weighted images, in three subjects, acquired with the same coil,
e coil elements.
linical applications
erebral perfusionature  and  the  access  to  a  reproducible  and  validated  quan-
iﬁcation  of  the  CBF  with  respect  to  other  cerebral  perfusion
ve all visible in the native images (upper line). They increase with
autocalibrating partially parallel acquisitions (GRAPPA) technique,
 sensitivity encoding technique (SENSE), they provide aliasing. On
e, but are responsible for an increase in noise.
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techniques  [38,47].  Several  recent  reviews  have  described
these  applications  [35,48,49].
The  value  of  ASL  has  been  demonstrated  in  acute
and  chronic  neurovascular  diseases  where  the  perfusion
anomalies  revealed  concord  with  other  techniques  (Fig.  15)
[50—52],  sometimes  with  an  overestimate  when  compared
with  perfusion  MRI  [53].  In  tumor  disorders,  ASL  speciﬁes  the
grade  of  the  tumor  and  measures  the  effects  of  antiangio-
genic  therapy  [54—56].  Local  changes  in  cerebral  perfusion
have  also  been  detected  in  epilepsy  and  neurodegenera-
tive  disease,  such  as  Alzheimer’s  disease  or  frontotemporal
dementia  [55,57].  The  latter  two  disorders  can  even  be
distinguished  by  ASL  with  their  different  proﬁles  of  perfu-
sional  abnormalities  [58].  In  amyotrophic  lateral  sclerosis,
the  reduction  in  perfusion  is  correlated  with  the  severity
of  the  disease  [59].  Several  rare  studies  have  examined
psychiatric  diseases,  in  particular  depression  [60,61],  sleep
deprivation  [62],  or  the  addictions  [63].  Certain  disorders,
such  as  multiple  sclerosis,  have  been  very  little  studied  by
ASL  [64].  Finally,  in  spite  of  the  advantages  of  ASL  in  the
pediatric  population,  in  particular  a  shorter  transit  time  and
a  higher  CBF  than  in  the  adult,  very  little  speciﬁc  works  has
been  carried  out  on  this  population  [65—67].
If  ASL  in  general  analyses  the  overall  cerebral  tissue
perfusion,  selective  labeling  methods  of  a  cervical  artery
also  analyze  the  perfusion  of  the  downstream  area  and  the
presence  of  possible  substitutes  for  this  area  via  the  devel-
opment  of  collaterality  [16,68].
Functional MRI with arterial spin labeling
(fASL)It  is  possible  to  obtain  mapping  of  brain  activation  by  the
analysis  of  the  time  course  of  the  perfusion  measured  by  ASL
during  an  activation  paradigm  (fASL)  and  by  directly  study-
ing  the  variations  in  perfusion  that  accompany  neuronal
o
t
a
[
Figure 15. Chronic thrombosis of the internal left carotid artery. a: the
left white matter; b: the T2*-weighted perfusion sequence of magnetic
increase in the mean transit time in the anterior part of the territory
perfusion anomaly is also visible on the mapping of the arterial blood sloe  1219
ctivation.  A  recent  review  has  described  this  technique  and
ts  applications  [69].
fASL  paradigms  have  explored  motor,  visual  and  language
unctions  [70—73]. fASL  has  also  explored  the  mecha-
isms  of  learning  and  memorization  [74],  stress  control
75]  or  pain  response  [76]. The  main  interest  over  the
OLD-fMRI  is  the  absolute  quantiﬁcation  of  CBF  varia-
ions  during  neuronal  activation  [70,77].  Several  recent
tudies  have  shown  that  fASL  beneﬁts  from  better  inter-
ndividual  [72]  and  intra-individual  [71]  reproducibility.
ASL  also  seems  to  be  more  precise  than  BOLD-fMRI  in
erms  of  temporal  resolution,  with  a more  synchronous
ignal  kinetics  of  neuronal  activation  [77]. Finally,  fASL
rovides  a  better  spatial  localization  of  neuron  activity
73].
xtra-cerebral applications of arterial spin
abeling
rom  the  beginning,  ASL  was  used  to  study  renal  per-
usion  [78].  The  measurements,  mainly  obtained  with  FAIR
echniques,  are  correlated  with  those  obtained  by  SPECT,
ncluding  cases  of  stenosis  of  the  renal  artery,  and  are
imilar  in  the  renal  cortex  to  those  with  T1-weighted
erfusion  MRI  [79,80]. A  recent  study  has  demonstrated
he  good  intra-  and  inter-session  reproducibility  of  these
easurements  [81].  The  feasibility  of  ASL  for  the  charac-
erization  of  renal  adenocarcinomas  and  their  monitoring
fter  ablation  by  radiofrequency  has  been  demonstrated
82,83].
With  the  technical  developments,  it  seems  possible  to
btain,  within  an  experimental  context,  information  about
he  perfusion  of  pathological  bone  or  the  pancreas,  or  even
n  organ  with  a  low  perfusion  level,  such  as  the  prostate
84—86].
 FLAIR axial section reveals a small ischemic sequela of deep frontal
 susceptibility, with the injection of gadolinium, demonstrates an
 of the left middle cerebral artery (arrow); c: a superimposable
w of the arterial spin labeling.
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onclusion
he  absence  of  irradiation  or  the  exogenous  injection  of  a
ontrast  medium,  as  well  as  the  access  to  a  reproducible
uantiﬁcation  of  perfusion  parameters,  make  ASL  an  espe-
ially  interesting  technique  in  the  study  of  tissue  perfusion,
n  particular  the  brain  and  kidney.  ASL  is  becoming  available
n  clinical  MRI  and  its  use  is  increasingly  easy.  Neverthe-
ess,  the  quality  of  ASL  images  may  be  limited  by  their
ow  signal-noise  ratio  and  by  several  types  of  artifacts  that
re  important  to  know.  In  addition,  homogenization  of  the
echniques  of  proton  labeling,  image  acquisition  and  data
rocessing  will  allow  for  the  large-scale  use  of  ASL  and
hereby  validate  its  potential  clinical  applications.
TAKE-HOME  MESSAGES
Advantages  of  ASL
• No  irradiation
• No injection  of  exogenous  contrast  medium
• Absolute  quantiﬁcation  possible  of  the  tissue  blood
ﬂow  and  the  arterial  transit  time
• Repeated  measurements  possible
• Reproducibility
Disadvantages  of  ASL
• Low  signal-noise  ratio
• Minimum  acquisition  time:  3  min
• Limited  spatial  resolution
• Quantiﬁcation  of  the  tissue  blood  volume  impossible
(ex:  cerebral  blood  volume)
• Absence  of  harmonization  of  techniques  (type
of  labeling,  image  acquisition,  post-treatment)
between  the  manufacturers
• Post-treatment  optimization,  automation  and
standardization  still  in  developmentigure 16. The T1 post-contrast axial slice shows annular contrast (a).
n the mapping calculated from the T2*-weighted perfusion sequence o
erfusion mapping obtained by arterial spin labeling before the injecti
rrow).J.-C.  Ferré  et  al.
linical case
his  55-year-old  woman  presents  a  left  parietal  expan-
ive  process  (Fig.  16).  The  T1  post-contrast  axial  section
eveals  annular  enhancement  (a).  An  increase  in  the  cere-
ral  blood  volume  is  visible  (white  arrow)  on  the  mapping
alculated  from  the  magnetic  susceptibility  of  gadolinium  in
 T2*-weighted  perfusion  sequence  (b).  The  perfusion  map-
ing  obtained  by  ASL  before  the  injection  of  gadolinium  (c)
lso  shows  this  hyperperfusion  in  a  ring  (black  arrow).  The
iagnosis  of  glioblastoma  is  made  after  examination  of  the
urgical  sample  taken  after  the  MRI.
uestions
.  What  is  the  main  perfusion  parameter  measured  by  ASL?
What  are  the  characteristics?
. What  are  the  main  advantages  and  disadvantages  of  ASL?
.  Why  is  the  use  of  a  3  T MRI  also  an  advantage  for  ASL?
nswers
.  The  CBF.  It  represents  the  amount  of  blood  that
passes  through  the  tissue  per  unit  of  time.  The  unit  is
mL/100  g/min.  The  quantiﬁcation  of  the  CBF  by  ASL  is
reliable,  reproducible  and  correlated  with  other  tech-
niques,  in  particular  the  techniques  of  nuclear  medicine.
By  using  multi-TI  techniques,  that  are  still  not  available
on  clinical  MRI,  it’s  possible  to  obtain  measurements  of
the  arterial  transit  time.  However,  the  measurement  of
the  cerebral  blood  volume  is  not  possible  with  ASL.
.  Provided  that  the  usual  contra-indications  are  complied
with  for  MRI,  ASL  is  a  completely  non-invasive  technique
to  study  perfusion  (no  ionizing  radiation,  no  exogenous
injection  of  contrast  media).  The  absolute  quantiﬁcation
of  the  CBF  is  possible  and  is  reliable  and  reproducible.
The  main  disadvantage  is  the  low  signal-noise  ratio
related  to  the  subtraction  between  ‘‘labeled’’  images
and  ‘‘control’’  images.  This  requires  a  minimum  acqui-
sition  of  3  min  and  a  spatial  resolution  that  is  inferior
that  of  the  other  techniques  (MRI  or  CT-scan).  The  multi-
plicity  of  acquisition  techniques  and  processing  currently
available  on  clinical  MRI  render  large-scale  use  difﬁcult.
 An increase in the cerebral blood volume is visible (b, white arrow)
f magnetic susceptibility with the injection of gadolinium (b). The
on of gadolinium (c) also shows this hyperperfusion in ring (black
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3.  The  increase  in  the  magnetic  ﬁeld  increases  the  signal-
noise  ratio.  Moreover,  since  the  relaxation  time  is  longer,
the  duration  of  the  labeling  increases.  The  increase  in
distortions  is  widely  compensated  at  the  encephalic  level
by  the  use  of  phased  array  coils  (the  signal  increases  with
the  number  of  elements,  near  the  elements,  as  well  as
at  the  center  of  the  image)  and  by  the  use  of  parallel
imaging.
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